A novel indirect immunofluorescence test for the detection of IgG and IgA antibodies for diagnosis of Hepatitis E Virus infections

Journal of Virological Methods

Volumn 191, Issue 1, 2013, Pages 48-54

  Osterman, Andreas ^a,b   Vizoso Pinto, Maria G ^a   Jung, Jette ^a   Jaeger, Gundula ^a   Eberle, Josef ^a   Nitschko, Hans ^a   Baiker, Armin ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Bavarian Health and Food Safety Authority   (Germany)

Author keywords

Hepatitis E Virus; IgA; IgG; Immunofluorescence test; Recombinant ORF2; Serologic assay

Indexed keywords

HEPATITIS ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ORF2 PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN;

ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; ENDEMIC DISEASE; HEPATITIS E; HUMAN; IMMUNOFLUORESCENCE; MAMMAL CELL; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROLOGY;

CLINICAL LABORATORY TECHNIQUES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

EID: 84877335581     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.03.022     Document Type: Article

References (40)

1. Arankalle V.A., Lole K.S., Deshmukh T.M., Chobe L.P., Gandhe S.S. Evaluation of human (genotype 1) and swine (genotype 4)-ORF2-based ELISAs for anti-HEV IgM and IgG detection in an endemic country and search for type 4 human HEV infections. J. Viral Hepat. 2007, 14:435-445.
2. Baiker A., Bagowski C., Ito H., Sommer M., Zerboni L., Fabel K., Hay J., Ruyechan W., Arvin A.M. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J. Virol. 2004, 78:1181-1194.
3. Drexler J.F., Seelen A., Corman V.M., Fumie T.A., Cottontail V., Melim Z.R., Gloza-Rausch F., Klose S.M., du-Sarkodie Y., Oppong S.K., Kalko E.K., Osterman A., Rasche A., Adam A., Muller M.A., Ulrich R.G., Leroy E.M., Lukashev A.N., Drosten C. Bats worldwide carry hepatitis E virus-related viruses that form a putative novel genus within the family Hepeviridae. J. Virol. 2012, 86:9134-9147.
4. Elkady A., Tanaka Y., Kurbanov F., Hirashima N., Sugiyama M., Khan A., Kato H., Okumura A., Mizokami M. Evaluation of anti-hepatitis E virus (HEV) immunoglobulin A in a serological screening for HEV infection. J. Gastroenterol. 2007, 42:911-917.
5. Faber M.S., Wenzel J.J., Jilg W., Thamm M., Hohle M., Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg. Infect. Dis. 2012, 18:1654-1657.
6. Fogeda M., de O.F., Avellon A., Echevarria J.M. Differential diagnosis of hepatitis E virus, cytomegalovirus and Epstein-Barr virus infection in patients with suspected hepatitis E. J. Clin. Virol. 2009, 45:259-261.
7. Gotanda Y., Iwata A., Ohnuma H., Yoshikawa A., Mizoguchi H., Endo K., Takahashi M., Okamoto H. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan. J. Med. Virol. 2007, 79:734-742.
8. Graff J., Zhou Y.H., Torian U., Nguyen H., St C.M., Yu C., Purcell R.H., Emerson S.U. Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J. Virol. 2008, 82:1185-1194.
9. He J., Tam A.W., Yarbough P.O., Reyes G.R., Carl M. Expression and diagnostic utility of hepatitis E virus putative structural proteins expressed in insect cells. J. Clin. Microbiol. 1993, 31:2167-2173.
10. Herremans M., Duizer E., Jusic E., Koopmans M.P. Detection of hepatitis E virus-specific immunoglobulin A in patients infected with hepatitis E virus genotype 1 or 3. Clin. Vaccine Immunol. 2007, 14:276-280.
11. Huang Y.W., Opriessnig T., Halbur P.G., Meng X.J. Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo. J. Virol. 2007, 81:3018-3026.
12. Jameel S., Zafrullah M., Ozdener M.H., Panda S.K. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 1996, 70:207-216.
13. Jimenez de.O.N., Galindo I., Girones O., Duizer E., Escribano J.M., Saiz J.C. Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae. J. Clin. Microbiol. 2009, 47:3276-3282.
14. Jimenez de.O.N., Escribano-Romero E., Blazquez A.B., Lorenzo M., Martin-Acebes M.A., Blasco R., Saiz J.C. Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses. J. Virol. 2012, 86:7880-7886.
15. Jothikumar N., Cromeans T.L., Robertson B.H., Meng X.J., Hill V.R. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J. Virol. Methods 2006, 131:65-71.
16. Lewis H.C., Wichmann O., Duizer E. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol. Infect. 2010, 138:145-166.
17. Ma H., Song X., Li Z., Harrison T.J., Zhang H., Huang W., Hao W., Kong W., Wang Y. Varying abilities of recombinant polypeptides from different regions of hepatitis E virus ORF2 and ORF3 to detect anti-HEV immunoglobulin M. J. Med. Virol. 2009, 81:1052-1061.
18. Mitsui T., Tsukamoto Y., Suzuki S., Yamazaki C., Masuko K., Tsuda F., Takahashi M., Tsatsralt-Od B., Nishizawa T., Okamoto H. Serological and molecular studies on subclinical hepatitis E virus infection using periodic serum samples obtained from healthy individuals. J. Med. Virol. 2005, 76:526-533.
19. Mohn U., Bauer P., Dorn S., Wochinz-Richter K., Motz M. Antibody-reactivity against the C-terminal part of open reading frame (ORF) 2 provides an indication of a past hepatitis E virus (HEV) infection. 19th Annual Meeting of the Society for Virology 2009, 18.
20. Mushahwar I.K. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. J. Med. Virol. 2008, 80:646-658.
21. Osterman A., Vizoso Pinto M.G., Haase R., Nitschko H., Jager S., Sander M., Motz M., Mohn U., Baiker A. Systematic screening for novel, serologically reactive hepatitis E virus epitopes. Virol. J. 2012, 9:28.
22. Schlauder G.G., Mushahwar I.K. Genetic heterogeneity of hepatitis E virus. J. Med. Virol. 2001, 65:282-292.
23. Surjit M., Jameel S., Lal S.K. Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum. J. Virol. 2007, 81:3339-3345.
24. Takahashi M., Kusakai S., Mizuo H., Suzuki K., Fujimura K., Masuko K., Sugai Y., Aikawa T., Nishizawa T., Okamoto H. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J. Clin. Microbiol. 2005, 43:49-56.
25. Takahashi M., Tamura K., Hoshino Y., Nagashima S., Yazaki Y., Mizuo H., Iwamoto S., Okayama M., Nakamura Y., Kajii E., Okamoto H. A nationwide survey of hepatitis E virus infection in the general population of Japan. J. Med. Virol. 2010, 82:271-281.
26. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., Reyes G.R. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991, 185:120-131.
27. Tian D.Y., Chen Y., Xia N.S. Significance of serum IgA in patients with acute hepatitis E virus infection. World J. Gastroenterol. 2006, 12:3919-3923.
28. Torresi J., Meanger J., Lambert P., Li F., Locarnini S.A., Anderson D.A. High level expression of the capsid protein of hepatitis E virus in diverse eukaryotic cells using the Semliki Forest virus replicon. J. Virol. Methods 1997, 69:81-91.
29. Torresi J., Li F., Locarnini S.A., Anderson D.A. Only the non-glycosylated fraction of hepatitis E virus capsid (open reading frame 2) protein is stable in mammalian cells. J. Gen. Virol. 1999, 80:1185-1188.
30. Tsarev S.A., Tsareva T.S., Emerson S.U., Kapikian A.Z., Ticehurst J., London W., Purcell R.H. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J. Infect. Dis. 1993, 168:369-378.
31. Vizoso Pinto M.G., Villegas J.M., Peter J., Haase R., Haas J., Lotz A.S., Muntau A.C., Baiker A. LuMPIS-a modified luminescence-based mammalian interactome mapping pull-down assay for the investigation of protein-protein interactions encoded by GC-low ORFs. Proteomics 2009, 9:5303-5308.
32. Weber-Mzell D., Kotanko P., Hauer A.C., Goriup U., Haas J., Lanner N., Erwa W., Ahmaida I.A., Haitchi-Petnehazy S., Stenzel M., Lanzer G., Deutsch J. Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur. J. Clin. Invest. 2004, 34:224-228.
33. Wenzel J.J., Preiss J., Schemmerer M., Huber B., Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J. Infect. Dis. 2013, 207:497-500.
34. Wichmann O., Schimanski S., Koch J., Kohler M., Rothe C., Plentz A., Jilg W., Stark K. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J. Infect. Dis. 2008, 198:1732-1741.
35. Wu K.T., Chung K.M., Feng I.C., Sheu M.J., Kuo H.T., Koay L.B., Lin C.Y., Tang L.Y., Tsai S.L. Acute hepatitis E virus infection in Taiwan 2002-2006 revisited: PCR shows frequent co-infection with multiple hepatitis viruses. J. Med. Virol. 2009, 81:1734-1742.
36. Wu T., Zhang J., Su Z.J., Liu J.J., Wu X.L., Wu X.L., Lin C.X., Ou S.H., Yan Q., Shih J.W., Xia N.S. Specific cellular immune response in hepatitis E patients. Intervirology 2008, 51:322-327.
37. Zacharias N.M., Athanassaki I.D., Sangi-Haghpeykar H., Gardner M.O. High false-positive rate of human immunodeficiency virus rapid serum screening in a predominantly hispanic prenatal population. J. Perinatol. 2004, 24:743-747.
38. Zafrullah M., Ozdener M.H., Kumar R., Panda S.K., Jameel S. Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein. J. Virol. 1999, 73:4074-4082.
39. Zhang F., Li X., Li Z., Harrison T.J., Chong H., Qiao S., Huang W., Zhang H., Zhuang H., Wang Y. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J. Med. Virol. 2006, 78:1441-1448.
40. Zhang S., Tian D., Zhang Z., Xiong J., Yuan Q., Ge S., Zhang J., Xia N. Clinical significance of anti-HEV IgA in diagnosis of acute genotype 4 hepatitis E virus infection negative for anti-HEV IgM. Dig. Dis. Sci. 2009, 54:2512-2518.